[1
]
From the Departments of Biostatistics and Clinical Research (J-J.P.), Infectious Diseases
(J.-J.P.), Surgical Intensive Care (V.P.), Medical Intensive Care (A.S., X.V., N.T.,
B. Sauneuf, D.C.), and Microbiology (V.C.), Centre Hospitalier Universitaire (CHU)
Caen, INSERM Unité Mixte de Recherche Scientifique 1075 COMETE (N.T.) and EA4655 Risques
Microbiens (J.-J.P., V.C., D.C.), Université de Caen Normandie, Caen, Department of
Medical Intensive Care, CHU Cochin (N.M., J.-P.M.), and Department of Medical and
Toxicologic Intensive Care, CHU Lariboisière (B.M.), Paris, Department of Anesthesiology
and Surgical Intensive Care, CHU Mondor, Créteil (N.M.), Department of Intensive Care
Medicine, Centre Hospitalier Général, Chartres (P.K.), Department of Intensive Care
Medicine, Centre Hospitalier Général, Versailles (A.G.), Department of Intensive Care
Medicine, Centre Hospitalier Général, Corbeil-Essonnes (S.M.), Department of Intensive
Care Medicine, Centre Hospitalier Général, Pontoise (S.M.), and Department of Intensive
Care Medicine, Centre Hospitalier Général, Saint-Lô (M.R., B. Savary) - all in France;
and the Rhode Island Hospital Department of Medicine, Division of Infectious Diseases,
Warren Alpert Medical School of Brown University, Providence (L.A.M.).